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ABSTRACT
The gold salt [(tht)AuCI] was reacted with [1-N,N-dimethylaminomthyl-2-
diphenylphosphino]ferrocene (1) forming the bimetallic derivative 4. The reaction of methyl iodide
and tetramethylammonium bromide on the chloride 4 produced the ammonium salt 5 and the
bromide 6 respectively. New aminophosphines 2 and 3, which represent two of the rare
phosphorylated metallocenes containing P(III)-N bond have also been coordinated to gold(I) to
form 7 and 8. The presence of the ethoxy group in 7 provides evidence for the lability of one
nitrogen-phosphorus bond. The X-ray structure of compounds 4 and 7 have been established.
Both crystallize in space group P21/c, monoclinic, with a 11.095(2) , b = 12.030(3) , c =
17.763(4) , I= 94.02(2), Z 4 for 4 and a 14.863(3) , b 8.036(5) , c 18.062(5)/,, I]
101.64(1), Z = 4 for 7.197Au MOssbauer data are in good agreement with those for other linear P-
Au-CI containing complexes. The compounds were evaluated for in vitro anti-tumour activity
against two human tumours. Differential cytotoxicity was observed with activity comparable to
cisplatin, with the exception of one compound which was significantly more cytotoxic.
Keywords: heteropolymetallic complexes (Fe, Au), antitumoural activity, X-ray structure, NMR and
197Au M6ssbauer spectroscopies
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INTRODUCTION
The antitumour activity of diphenylphosphine complexes is of recent interest and it has been
proved that the coordination of the diphosphine to gold(I) enhances the cytotoxicity, z,2 Moreover
the intimate association of two therapeutic metals in the same molecule could give the possibility of
a synergism between them. With this objective in mind, we have prepared gold(I) derivatives of
compounds similar to [FcCH2NHMe2]+[CI]" (Fc Xl5-C5H5FeC5H4) which itself exhibits significant
antitumour activity3. We report here the synthesis and comparative in vitro cytotoxicity of the
(diphenylphosphino)chlorogold(I) complex obtained from [FcCH2NMe2]), the corresponding
iodide salt, the bromide derivative, new ferrocenylphosphines and their gold(I) complexes.
MATERIALS AND METHODS
All reactions were conducted under an atmosphere of pure dry argon. Solvents were dried
and deoxygenated over sodium/benzophenone ketyl and distilled immediately before use.
CH2CI2 stabilized with 0.3 % ethanol was purchased from SDS Company. Transfers were carried
out via syringes or cannulas.
Microanalyses were performed by the Microanalysis Centre in UMIST (Manchester, U.K.).
Melting points were determined with a Kofler apparatus without correction. 1 H, 13C{1H}, 19F and
31p nuclear magnetic resonance spectra were recorded in CDCI3 with a Bruker AC 200
spectrometer operating at 200.0, 50.3, 187.8 and 81.0 MHz respectively. Chemical shifts are
reported in > units, pads per million downfield from internal tetramethylsilane for 1 H, 13C{1 H} and
from external H3PO4 for 31 p.
The M6ssbauer spectra were obtained in the Technische Universit&t M0nchen (Garching,
Germany). The 197pt activity feeding the 77.3 keV MSssbauer transition was produced by
irradiation of enriched 196pt metal. Both source and absorber were kept at 4.2 K, a sinuso’[dal
velocity wave form and an intrinsic Ge detector were used. A sample of the absorber with of ca. 50
mg(Au).cm"2 was used, spectra were fitted to Lorentzian lines.
L|gand Synthesis
[Na(AuCI4), 2H20] was a generous gift from Johnson Matthey Technology Centre. (1-N,N-
dimethylaminomethyl-2-diphenylphosphino)ferrocene (1),4, 5, 6[(tht)AuCi],7 [CIP(NMe2)2] and
[H2CN(CH3)PN(CH3)CH2]ClSwere prepared by literature methods.
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[1-N,N-dimethylaminom6thyl-2-bis(dimethylamino)phosph inolferrocene (2)
A solution of BuLi in hexane 1.45 M (4.30 ml, 6.17 mmol) was added dropwise to a stirred
suspension of N,N-dimethylaminomethylferrocene (1.50 g, 6.17 mmol) in diethylether (5 ml) at 0
C. Stirring was maintained until the precipitate of o-lithioamine appeared. This monolithioamine was
reacted with [CIP(NMe2)2] (0.95 g, 6.17 mmol) and the resultant mixture was heated under reflux
for I hr. The white solid (LiCI) was filtered off and the solvent was taken off. The oil obtained was
recrystallized from pentane at -78 C yielding 0.60 g (27 %) of a pure brown oil (at room
temperature). Anal. Calcd. forC17H28FeN3P:C, 56.5; H, 7.8; N, 11;6; Fe, 15.4. Found: C, 56.6;
H, 7.6; N, 11.3; Fe, 15.1.1H NMR(C6D6)" 2.15 (s, 6H, CH2NMe2), 2.63, 2.72 (d, 6 H, 3JH.P 9
Hz, PNMe2), 3.16 (d, 1 H, 2JH.H 13 Hz, CH2), 3.56 (dd, 1 H, 2JH.H = 13 Hz, 4JH.P = 2 Hz,
CH2),4.10 (s, 5 H, Cp), 4.08- 4.13, 4.23- 4.26, 4.32- 4.37 (m, 1 H, Cp). 3 1p NMR: 93.4 (s). 1 3c
NMR(C6D6): 41.3, 42.1 (d, 2Jc.p 17Hz, PNMe2), 45.7 (s, CH2NMe2), 58.8 (d, 3Jc.p 10 Hz,
CH2), 68.2, 70.4, 71.1, 72.8 (s, Cp), 69.6 (d, 1jc.p = 79 Hz, C ipso), 88.2 (d, 2Jc.p 19 Hz, C-
CH2).
[ 1 -N,N-d methy am nomethyl-2-((N,N-d methyl)-2,5-d aza- 1 -phosph olanyl)]-
ferrocene (3)
A solution of BuLi in hexane 2.35 M (2.40 ml, 5.58 mmol) was added dropwise to a stirred
suspension of N,N-dimethylaminomethylferrocene (1.36 g, 5.58 mmol) in diethylether (5 ml) at 0
C. Stirring was maintained until the precipitate of o-lithioamine appeared.
[H2CN(CH3)PN(CH3)CH2]CI (0.85 g, 5.58 mmol) was added to the lithioamine and the resultant
mixture was heated under reflux for I hr. The white solid (LiCI) was filtered off and the solvent was
eliminated under vaccum. The solid obtained was recrystallized from pentane yielding 0.60 g (27
%) of pure orange crystals.Mp: 84 C. Anal. Calcd. for C17H26FeN3P: C, 56.8; H, 7.3; N, 11.7; Fe,
15.5. Found" C, 56.9; H, 8.0; N, 11.2; Fe, 14.6. 1 H NMR (C6D6): 2.10 (s, 6 H, CH2NMe2), 2.57,
2.81 (d, 3 H, 3JH.p 14 Hz, PNMe), 2.66-2.93 (m, 3 H, PNCH2), 2.79 (d, 1 H, 2JH.H 12 Hz,
CH2NMe2), 3.11-3.15 (m, 1 H, PNCH2), 3.98 (dd, 1 H, 2JH.H = 12 Hz, 4JH.P = 2 Hz, CH2NMe2),
4.01-4.04, 4.07-4.11, 4.13-4.17 (m, 1 H, Cp), 4.12 (s, 5 H, Cp), 3 1p NMR: 100.2 (s). 1 30 NMR
(C6D6): 36.0, 39.9 (d, 2Jc.p 15 Hz, PNMe), 45.2 (s, CH2NMe2), 54.2, 55.2 (d, 2Jc.p = 9 Hz,
PNCH2), 58.6 (d, 3Jc-p 8 Hz, CH2NMe2), 68.5, 69.2, 71.5, 73.4 (s, Cp), 82.3 (d, 1JC-P 54 Hz,
C ipso), 90.2 (d, 2Jc-p 21 Hz, C-CH2).
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(4)
Synthesis of Gold(I) Complexes
( 1 -N,N-d methylami nomethyl-2-ch orogold(I)d phenylphosph no)ferrocene
A solution of 1 (0.163 g, 0.382 mmol)in methylene chloride (20 ml) was added to a solution
of [(tht)AuCI] (0.123 g, 0.382 mmol) in the same solvent (20 ml) at room temperature. Stirring was
maintained for two hours and the solvent was then evaporated. The orange residue was
recrystallized from toluene. Yield (0.186 g, 73 %). Mp: 206 C. Anal. Calcd. for C25H26AuCIFeNP:
C, 45.5; H, 4.0; N, 2.1 Fe, 8.5. Found" C, 45.5; H, 3.9; N, 2.1; Fe, 8.0. 1 H NMR (C6D6): 1.86 (s, 6
H, Me), 2.70, 4.66 (d, 1 H, 2JH.H = 13 Hz, CH2), 3.55-3.59, 3.83-3.86, 4.08-4.11 (m, 1 H, Cp),
3.99 (s, 5 H, Cp), 6.81-7.04 (m, 6 H, m-H, p-H), 7.16-7.31, 7.54-7.69 (m, 2 H, o-H), 3 1p NMR"
20.2 (s). I 30 NMR (CDCI3): 44.5 (s, Me), 58.7 (s, CH2), 69.4 (d, 1jc.p 73 Hz, C ipso), 69.8,
73.7, 75.2 (d, JC-P = 8, 5, 8 Hz, Cp), 70.9 (s, Cp), 90.2 (d, 2Jc-P = 14 Hz, C-CH2), 128.4, 128.7 (d,
JC-P 12 Hz), 130.3, 131.7 (d, 1jc.p 65 Hz, C ipso), 130.9, 131.7 (s, p-C), 133.1, 134.8 (d, JC-
p = 14 Hz). 1 9 7Au M6ssbauer (mm.s’l): QS = 7.71, IS = 4.19.
Ammonium salt from (1-N,N-dimethylaminomethyl-2-iodogold(I)-
diphenylphosphino)ferrocene(5)
Two equivalents of methyl iodide was added to a solution of 4 (0.106 g, 0.160 mmol) in
acetonitrile (20 ml) at room temperature. On addition of diethylether an orange powder was formed.
This powder does not melt but darkened and decomposed from 202 C. Yield (0.102 g, 71%).
Anal. Calcd. for C26H29AuFe12NP: C, 35.0; H, 3.3; N, 1.6; I, 28.4. Found: C, 35.6; H, 3.2; N, 2.2; I,
27.0. 1 H NMR (CH3CN)" 2.16 (s, 6 H, Me), 4.84, 5.70 (d, 1 H, 2JH.H 14 Hz, CH2), 3.98-4.06,
4.90-4.95, 5.07-5.12 (m, 1 H, Cp), 4.26 (s, 5 H, Cp), 7.45-7.73 (m, 8 H, m-H, p-H, o-H), 7.83-7.99
(m, 2 H, o-H), 3 1p NMR: 29.9 (s).
( 1 -N,N-d methylam nomethyl-2-bromogold(I)d phenylphosph no)-ferrocene
(6)
A solution of I=t4NBr (0.062 g, 0.296 mmol)in ethanol (20 ml) was added to a slurry of 4
(0.098 g, 0.148 mmol) in the same solvent (20 ml) at -60 C. Stirring was maintained for a few hours
during which the solution warmed slowly to room temperature. The orange solid formed was
isolated and washed with ethanol and diethylether. It did not melt but darkened and decomposed
from 206 C. Yield (0.085 g, 82 %). Anal. Calcd. for C25H26AuBrFeNP: C, 42.6; H, 3.7; N, 2.0; Br,
11.4. Found: C, 42.7; H, 3.7; N, 2.1; Fe, 11.6. 1H NMR(C6D6): 1.89 (s, 6H, Me), 2.72, 4.71 (d, 1
H, 2JH-H = 13Hz, CH2), 3.60-3.64, 3.88-3.92, 4.10-4.14 (m, 1 H, Cp), 4.06 (s, 5 H, Cp), 6.85-7.10
(m, 6 H, m-H, p-H), 7.22-7.35, 7.61-7.73 (m, 2 H, o-H), 3 1p NMR: 25.8 (s).
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[1 -N,N-d methylaminomethyI-2-(ch orogold(I)d methylaminoethoxy)-
phosphino]ferrocene (7)
This compound was prepared from 2 (0.608 g, 1.680 mmol) and [(tht)AuCI] (0.540 g, 1.608
mmol) by a procedure similar to that given for 4. The orange solid was recrystallized from pentaneo
Yield (0.180 g, 20 %). Mp: 116 C. Anal. Calcd. for C17H27AuCIFeN2OP: C, 34.3; H, 4.6; N, 4.7;
Fe, 9.4. Found" C, 34.7; H, 4.6; N, 4.8; Fe, 8.9. 1 H NMR (C6D6)" 1.00 (t, 3 H, OCH2CH3), 2.01 (s,
6 H, CH2NMe2), 2.31 (d, 6 H, 3JH.P 11 Hz, PNMe2), 2.67 (d, 1 H, 2JH.H = 13 Hz, CH2NMe2),
3.42-3.75 (m, 2 H, OCH2CH3), 4.47 (d, 1 H, 2JH.H 13 Hz, CH2NMe2), 3.89- 3.94, 3.97- 4.04,
4.29- 4.33 (m, 1 H, Cp), 4.18 (s, 5 H, Cp). 3 1p NMR" 115.7 (s). 1 3c NMR(C6D6): 16.3 (d, 3JC-p
= 8.4 Hz, OCH2CH3), 38.1 (d, 2Jc-p = 9 Hz, PNMe2), 44.8 (s, CH2NMe2), 58.9 (d, 3Jc-p 2 Hz,
CH2NMe2), 64.2 (s, OCH2CH3), 68.8, 72.4, 74.4 (d, JC-P = 8, 3, 9 Hz, Cp), 71.0 (s, Cp), 72.7 (d,
1jc.p = 107 Hz, C ipso), 89.8 (d, 2Jc-p = 21 Hz, C-CH2). 1 9 7Au M6ssbauer (mm.s"1 )" QS =
7.74, IS 4.46.
[1 -N,N-dimethylsminomethyl-2-(N,N-dimethyl-2,5-diaza-chlorogold(I)-
1-phospholanyl)]ferrocene (8)
This compound was prepared from 3 (0.494 g, 1.374 mmol) and [(tht)AuCI] (0.441 g, 1.374
mmol) by a procedure similar to that given for 4. The orange solid was recrystallized from
toluene/pentane. Yield (0.183 g, 22 %). Mp: 150 C. Anal. Calcd. for C17H26AuCIFeN3P: C, 34.5;
H, 4.4; N, 7.1; Fe, 9.4. Found" C, 34.7; H, 4.4; N, 7.1; Fe, 9.1. 1H NMR (C6D6): 2.12 (s, 6 H,
CH2NMe2), 2.40, 2.43 (d, 3 H, 3JH.P = 14 Hz, PNMe), 2.36-2.52 (m, 3 H, PNCH2), 2.53 (d, 1 H,
2JH.H 13 Hz, CH2NMe2), 2.67-2.74 (m, 1H, PNCH2), 4.60 (d, 1 H, 2JH.H 12 Hz, CH2NMe2),
3.84- 3.89, 3.93-3.95, 4.00-4.04 (m, 1 H, Cp), 4.14 (s, 5 H, Cp), 3 1p NMR: 103.2 (s). 1 3C NMR
(C6D6)" 34.3, 36.3 (d, 2Jc.p 11 Hz, PNMe), 44.7 (s, CH2NMe2), 51.5, 52.0 (s, PNCH2), 58.8 (s,
CH2NMe2), 69.4, 72.4, 75.7 (d, JC-P 8, 10, 7 Hz, Cp), 70.2 (s, Cp), 77.3 (d, 1jc.p 62 Hz, C
ipso), 89.1 (d, 2Jc-p = 10 Hz, C-CH2). 1 97Au M6ssbauer(mm.s-1): QS = 7.47, IS 4.48.
Crystallographic Studies
Orange crystals of 4 and 7 were grown from toluene and pentane solutions, respectively. They
were mounted on an Enraf-Nonius CAD4 diffractometer. The pertinent crystallographic data are
given in Table I. The unit cells were determined from 25 randomly selected reflections (8<6<18).
The intensity data were collected at room temperature with o/20 scan up to emax 25. The Enraf-
Nonius Molen package was used for preliminary treatement of data. The intensities were corrected
for standard Lorentz and polarisation effects and empirical absorption correction applied for both
crystals. The structures were solved and refined by conventional three-dimensional Patterson,
difference Fourier, and full-matrix least-squares methods by using the SHELX76 package. All non-
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hydrogen atoms in both structures were refined with anisotropic temperature factors. The
hydrogen atoms were placed in calculated positions and were given riding on the atoms bearing
them. The highest peaks in the final difference map are in close proximity to the gold atoms. Final
atomic coordinates are given in Tables II and II1. Tables of hydrogen atom positions, anisotropic
temperature factors and observed and calculated structure factors may be obtained from the
authors (MMK)
Table I. Crystallographic Data for [Fc(CH2NMe2)(PPh2AuCI)] (4) and
[Fc(CH2NMe2XP(NMe2)(OCH2CH3)(AuCI)] (7)
chem. formula C25H26AuCIFeNP C17H27AuCIFeN20P
mol wt 659.73 594.66
color yellow yellow
dimensions 0.35 x 0.25 x 0.08 0.15 x 0.10 x 0.10
space group P21/c (No.14) P21/c (No. 14) a 11.095(2) 14.863(3)
b , 12.030(3) 8.036(5)
c,, 17.763(4) 18.062(5)
i deg 94.02(2) 101.64(1
V3 2365.1 2112.9
Z 4 4
dcalcg.cm"3 1.85 1.87
F(000) 1280 1152 , (Mo Kc) ,, 0.73071 0.73071
I (Mo K) crn"1 69.92 78.20
temperature, K 291 291
scan type -
2e -
2e
e range, deg 2 25 2 25
linear decay, % -5.3 (corrected) -4.0 (corrected)
tot. no. of refls 4835 4142
unique data I> 3o(I) 3149 2354
no. of variables 271 217
absorption correction ( scan) 71.520 99.969 67.553-99.814
R 0.023 0.037
Rw 0.027 0.039
GOF 0.815 1.188
weighting scheme
w= 1/(o2(F) + g F2), g 0.00138 0.00077
residual density, e/,-3 0.71 1.1
Biological Studies
Evaluation of potential anti-tumour activity was conducted against two human tumour cell
lines, the SW620 colon carcinoma9 and the HT1376 bladder caminoma] The cell lines were
obtained from the ECACC. The cells were seeded onto 96-well microtitre plates at a concentration
316M. Viotte, B. Gautheron, M.M. Kubicki, 3letal-BasedDrugs
LE. Nifantev and S. P. Fricker
of 5 x 104 105 coils ml"1 Altar a 24 hour pro-incubation poriod, tho coils woro troatod with tost
ompound for 4 hours at conontrations of 0 200 pg ml-1. Tho compound was than roplacod with
frosh modium and tho olls woro inubatod for a furthor 72 hours. Gall growth was assayod using
sulforhodamino B. Goll survival (%) was alculatod rolativo to untroatod control olls. Doso/survival
urvos woro onstructod from this data and tho IGs0 (concontration of compound giving 50 %
survival) alulatod.
Table II. Atomic Coordinates for [Fc(CH2NMe2)(PPh2AuCI)] (4)
:.::.... Atom’ x y z Beq(/,3’) ]
Au 0.23768(2) 0.39337(2) 0.35602(1 2.937(6)
Fe 0.34965(6) 0.04916(7) 0.36027(4) 2.36(2)
CI 0.1998 (1) 0.4997 (1) 0.2511 (1) 4.48(4)
P 0.2794 (1) 0.2886 (1) 0.4576 (1) 2.73(3)
N 0.0045 (4) 0.2062 (4) 0.3917 (2) 3.54(11)
C1 0.2729 (4) 0.1421 (4) 0.4396 (3) 2.84(11)
C2 0.1832 (4) 0.0844 (4) 0.3948 (3) 2.98(12)
C3 0.2073 (5) -0.0312 (4) 0.4029 (3) 3.83(14)
C4 0.3132 (5) -0.0454 (4) 0.4522 (3) 3.75(14)
C5 0.3549 (4) 0.0602 (4) 0.4753 (3) 3.25(13)
C6 0.0816 (4) 0.1361 (5) 0.3465 (3) 3.26(13)
C7 -0.0766 (5) 0.2724 (5) 0.3436 (3) 4.81(17)
(38 -0.0617 (5) 0.1393 (6) 0.4432 (4) 4.70(17)
Cll 0.4194 (8) 0.1493 (6) 0.2823 (4) 6.11(23)
C12 0.3417 (7) 0.0726 (8) 0.2465 (4) 6.74(25)
C13 0.3855 (8) -0.0334 (7) 0.2647 (4) 6.71(26)
C14 0.4902 (8) -0.0220 (7) 0.3097 (5) 6.68(25)
C15 0.5130 (7) 0.0902 (9) 0.3210 (5) 7.49(31)
C21 0.1811 (4) 0.3072 (4) 0.5339 (3) 3.05(12)
C22 0.1218 (5) 0.4083 (4) 0.5415 (3) 3.72(14)
C23 0.0438 (5) 0.4230 (5) 0.5974 (3) 4.39(16)
C24 0.0197 (5) 0.3358 (6) 0.6458 (3) 4.45(16)
C25 0.0798 (5) 0.2366 (6) 0.6392 (3) 4.52(16)
C26 0.1598 (5) 0.2217 (4) 0.5847 (3) 3.56(13)
C31 0.4325 (4) 0.3165 (4) 0.4981 (3) 3.05(12)
C32 0.4643 (5) 0.3123 (5) 0.5750 (3) 4.09(15)
C33 0.5796 (6) 0.3346 (5) 0.6026 (4) 5.07(18)
C34 0.6668 (6) 0.3588 (5) 0.5545 (4) 5.08(19)
C35 0.6376 (5) 0.3651 (6) 0.4794 (4) 5.27(19)
C36 0.5202 (5) 0.3450 (6) 0.4494 (3) 4.69(17)
Beq values are defined as" 8/3n2(U11 + U22 + U33).
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The sulforhodamine B(SRB) assay was performed as previously described11. The cells were
fixed with 200 pl 10% trichloroacetic acid for 30 minutes at 4C, washed five times in tap water and
stained with 100 pl 0.1% SRB in 1% acetic acid for 15 minutes. The cells were washed four times
with 1% acetic acid and air dried. The stain was solubilised in 200 pl 10 mM unbuffered Tris base.
Absorbance was measured at 540 nm using a microtitre plate reader.
Table III. Atomic Coordinates values for
[Fc(CH2NMe2)(P(NMe2)(OCH2CH3)(AuCI)] (7)
Atom x y z ’. Beq(/’2)..
Au 0.25436 (6) 0.52238 (9) -0.03566 (4) 5.05(1)
Fe 0.1558 (2) 0.5592 (3) 0.1762 (1) 5.48(4
P 0.2432 (4) 0.7451 (5) 0.0347 (3) 4.80(6
CI 0.2670 (4) 0.2951 (7) -0.1105 (3) 7.99(9
O 0.1479 (8) 0.843 (2) 0.0095 (7) 5.9(2)
N1 0.436 (1) 0.563 (2) 0.1366 (9) 6.3(2)
N2 0.325 (1) 0.881 (2) 0.0320 (8) 6.0(2)
C1 0.086 (2) 0.417 (3) 0.092 (1) 9.4(5)
C2 0.024 (2) 0.518 (3) 0.120 (1) 9.9(5)
C3 0.033 (1) 0.476 (4) 0.198 (2) 8.7(5)
C4 0.100 (2) 0.354 (3) 0.219 (1) 8.2(4)
C5 0.132 (2) 0.315 (3) 0.151 (2) 8.9(5)
C6 0.238 (1) 0.711 (2) 0.1304 (9) 5.1(2)
C7 0.292 (1) 0.605 (2) 0.183 (1) 5.5(3)
C8 0.269 (1) 0.622 (3) 0.257 (1) 6.7(3)
C9 0.202 (1) 0.754 (2) 0.251 (1) 7.3(3)
C10 0.182 (1) 0.807 (2) 0.1749 (9) 5.9(3)
C 11 0.360 (1) 0.468 (2) 0.162 (1) 5.5(2)
C12 0.493 (1) 0.436 (3) 0.107 (1) 8.0(4)
C13 0.492 (2) 0.663 (3) 0.200 (1) 9.7(4)
C14 0.396 (1) 0.855 (3) -0.013 (1) 7.8(4)
C15 0.336 (2) 1.033 (3) 0.079 (1) 8.7(4)
C16 0.122 (2) 0.890 (3) -0.073 (1) 7.1(3)
C17 0.057 (2) 1.029 (4) -0.079 (1) 10.2(5)
Anisotropically refined atoms are given in the form of the isotropic equivalent displacement
parameter defined as: (4/3) [a2*B(1,1) + b2*B(2,2) + c2"B(3,3) + ab(cos y )*B(1,2)
+ ac(cos I])*B(1,3) + bc(cos e)*B(2,3)]
RESULTS AND DISCUSSION
Synthetic Studies
Compounds 1,2 and 3 contain both "soft" (P) and "hard" (N)ligands. It is well known that the
former site is normally prefered for coordination by a "soft" metal like gold(I). This has been verified
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when the gold salt [(tht)AuCI] was reacted with [1-N,N-dimethylaminomthyl-2-
diphenylphosphino]ferrocene (1) forming the bimetallic derivative 4 (Scheme 1)
Scheme 1.
\/Ph
PPh2 P--AuCI
CH2NMe2 (tht)AuCLC
Fe ,- Fe
1 4
C H2N+Me3, I
Fe
H2NMe2
Ph\/Ph
2Et’Br,
P--AuBr
C H2NMe2
Fe
Regarding the positive antitumoral response of 1 before coordination and the inversion in
selectivity after coordination with gold (see after), we have decided to synthesize other N- and P-
containing derivatives by two different approaches consisting of modification of (1-N,N-
dimethylaminomethyl-2-chlorogold(I)diphenylphosphino)ferrocene (4) or by using new starting
phosphines.
Then two new complexes were synthesized from 4. The reaction of two equivalents of
methyl iodide with 4 produced the corresponding salt (5) (the substitution of the chlorine atom by
iodine was observed). The bromide 6 was obtained by reacting tetraethylammonium bromide with
the chloride 4 (Scheme 1).
The second approach (Scheme 2) allowed the two metallophosphines 2 and 3 to be
synthesized by reacting (N,N-dimethylaminomethyl)ferrocene with BuLi and [CIP(NMe2)2] for 2 or
BuLl and [H2CN(CH3)PN(CH3)CH2]CI for 3. They represent two of the rare phosphorylated
metallocenes containing P(III)-N bond12 which can be coordinated to gold. The unexpected
presence of the ethoxy group in 7 is due to the ethanol (0.3 %) used as stabilizer in the commercial
CH2CI2 and the transformation shows evidence for the lability of one of the nitrogen-phosphorus
bonds. The 1 H NMR spectrum in particular exhibits one triplet at 1 ppm (OCH2CH3) and one large
multiplet (3.42-3.75 ppm)corresponding to the two diastereotopic protons of OCH2CH3
319Vol. 2, No. 6, 1995 Synthesis, Structure ofNitrogen-Containing Phosphinogold(I) Ferrocenes
multicoupled to each other, with the phosphorus atom and methyl protons. We have not tried to
discard ethanol from methylene chloride.
The 1 H and 13C NMR spectra of each compound reflects the diastereotopy of the PNMe2
methyl substituents, the phenyl protons, and the methylene protons of CH2NMe2. In contrast, the
methyl part of CH2NMe2 consists of one singlet. The deshielding observed for one proton of the
methylene group of CH2NMe2 is probably due to an agostic bond involving the gold atom.
Interactions of this type have already been mentioned in the literature 3, 4 for other electrophilic
metals and our finding seems to be one of the first examples reported for gold 5.
The very large deshielding of the 31p signal for a bimetallic complex compared to the
corresponding Au- free one is evidence for the coordination to gold.
197Au MSssbauer data for 4, 7 and 8 are in good agreement with those for linear gold(I)
compounds such as [dppf(AuCl)2]6 and [Ph3PAuCI]7,8. The values observed for QS and
IS by reference to gold metal lie in the ranges 7.47 7.71 mm s"1 and 4.19 4.48 mms"1
respectively.
Scheme 2.
1) BuLip"
Fe 2) Cl
2
Me2NXp/NMe2
7--C H2NMe2
-’C H2NMe2
Fe
H3C--N N ---C H3 \/ Bu
P
Fe
(H3 3
H2NMe2
Me2N \/OCH2C H3
P--AuCI
C H2NMe2 (tht)AuCI
C H2CI2 (C2H5OH) Fe
(tht)AuCI
H3C--N N--CH3 \/
P--AuCI
C H2NMe2 --
Fe
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Structural Studies
The structure of compounds [Fc(CH2NMe2)(PPh2)AuCI] (4) and [Fc(CH2NMe2)(P(NMe2)
(OCH2CH3)(AuCI)] (4) were determined by X-ray diffraction.
[Fc(CH2NMe2)(PPh2AuCI)] (4)
Figure I shows an ORTEP plot of one of the two enantiomers and Table IV contains selected
bond lengths and bond angles. The cyclopentadienyl rings are eclipsed and parallel. The
phosphorus and nitrogen atoms deviate from the best plane of substituted C1-C5 ring towards the
iron atom by 0.15 and 1.13, respectively, while the C6 and gold atoms deviate from this plane by
0.03 and 1.09 . to the other side with respect to the iron atom. The nitrogen atom has a pyramidal
geometry. The positions of methyl groups (C7 and C8) indicate the orientation of the nitrogen
electron lone pair in the direction of gold, which might suggest an intramolecular Au-N interaction.
However, such an interaction is excluded on the basis of extended H0ckel MO calculations which
show a slightly negative value of Au-N overlap. Thus, the gold atom is not perturbed by secondary
interaction and exhibits an essentially linear geometry (Table IV). The Au-P and Au-CI distances are
close to the values observed in compounds with P-Au-CI linkage16"19.
Figure 1. ORTEP drawing of [Fc(CH2NMe2)(PPh2AuCI)] (4)
C12
C7
CI
C1
Au
C21
C22
C31
C32
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Table IV. Selected Interatomic Distances (/.) and Angles (o) for
[Fc(CH2NMe2)(PPh2AuCl)] (4)
Au...N 3.53(1) P -C1
Au...Fe 4.322(2) N -C6
Au -CI 2.276(3) N-C7
Au- P 2.222(3) N-C8
P- C21 1.81(1) C2-C6
P- C31 1.83(1
CI Au P 178.5(1 N C6 C2
Au- P-C1 114.3(3) C6-N-C7
Au P C21 115.8(4) C6 N C8
Au- P-C31 110.5(4) C7-N-C8
C1 C2-C6 127(1)
1.79(1)
1.48(2)
1.44(3)
1.46(2)
1.50(2)
111.6(9)
111(1)
111(1)
111(1)
[Fc(CH2NM e2)(P(NMe2)(OCH2C H3)(AuCI)] (7)
The presence of the ethoxy group has been confirmed by X-ray diffraction. A perspective
drawing of one of the four isomers is represented in Figure 2. Selected bond lengths and angles
are given in Table V. The cyclopentadienyl rings are essentially eclipsed and parallel. Contrary to
the structure of 4, the phosphorus and nitrogen atoms deviate (0.10 and 1.21 , respectively) from
the best plane of C6-C10 ring to the opposite side with respect to the iron atom, while the C11 and
Au atoms (deviations of 0.06 and 1.11 , respectively) are located between the planes of the Cp
rings. Similarly to the structure of 4, the nitrogen atom of the CH2NMe2 substituent (N1) has a
pyramidal geometry, while the N2 bound to the phosphorus is planar. The sum of the three angles
around N2 atom is equal to 359.9(9). This indicates the presence of d(P)-p(N2) interaction. The
P-N2 bond length of 1.640(9)A is effectively intermediate between the values observed for
phosphorus-nitrogen single and double bond2. On the other hand the P-O distance of 1.605(6)/,
corresponds very well to the P-O single bond distance observed in P-O-C organic and inorganic
linkages 2o,2 ]. Even if the lone pair of the N1 atom roughly heads for the gold atom, the Au-N1
distance of 3.70(1)/, is longer than in 4. Thus, we did not look for the existence of Au-N1
interaction. As expected, the P-Au-CI bonding is linear.
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Figure 2. ORTEPdrawing of [Fc(CH2NMe2)(P(NMe2)(OCH2CH3)(AuCI)] (7)
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Ci7
C
C i 0
C9, C8
Ci31
Table V. Selected Interatomic Distances (A) and Angles () for
[Fc(CH2NMe2)(P(NMe2)(OCH2CH3)(AuCI)] (7)
Au...N1 3.70(1) P-0 1.605(6)
Au...N2 3.22(1) P- N2 1.640(9)
Au...Fe 4.374(1) P-C6 1.797(9)
Au...O 3.21(1) N1 -Cll 1.47(1)
Au CI 2.303(3) N1 C12 1.44(2)
Au P 2.220(2) N1 C13 1.42(2)
N2 C14 1.48(3) N2- C15 1.48(2)
CIAuP 178.7(1) OPC6 97.7(4)
AuPO 114.1(2) N2PC6 107.9(4)
AuPN2 111.1(3) PN2C14 125.1(7)
AuPC6 117.9(3) PN2C15 122.3(9)
OPN2 106.9(4) C14N2C15 112.5(9)
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Anti-tumour Testing
The compounds were evaluated for potential anti-tumour activity using an in vitro screen
composed of two human tumour cell lines, SW620 and HT1376. This approach has been adopted
as in vivo screens for anti-tumour agents using transplantable murine tumours such as the L1210
and P388 leukaemias have had limited success in identifying drugs with activity against human solid
tumours22. The two cell lines exhibit differential chemosensitivity towards the metal anti-tumour
drug cisplatin with typical IC5o values of 9.3 +/- 1.5/Jg m1-1 for HT1376 and 29.5 + 3.1/Jg ml"1 for
$W620 (errors represent standard error of the mean, n = 9). Differential cytotoxicity is used as an
indicator of anti-tumour activity whereas similar toxicity against both cell lines is taken as an indicator
of non-specific cytotoxicity23 The ratio of the highest IC50 to the lowest IC50 is a useful measure of
differential cytotoxicity, this ratio is 3.2 for cisplatin.
The results for seven compounds are shown in Table VI.
Table VI. IC50 (lg.ml"1)
Cell line HT1376 SW620
Compound, (Bladder) (Colon)
,PPh
=--
CHNMe=
1
Ph/Ph
P-AuCI
-CH2N
Ph_/Ph
P--Aul
I"
16.2 73.0
Ph/Ph
P--AuBr
pCH2NMe
6
10.2
Cell line HT1376 SW620
Compound (Bladder) (Colon)
MeaN OCH2CI-j \/-.AuCl
CH2NMe= 1.5 7.4
7
H3C---N N--CH
pCH2NMe
Fe
3
HC--N N --CH /--AuCI
8
inactif > 200
1.3 19.6
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Goordination of gold to compound 1 to givo compound 4 rosults in a slight ovorall ineroaso in
eytotoxieity with an apparont invorsion of tho difforontial eytotoxieity in favour of tho $W620 coil
line. The differential however is not as great as that seen with cisplatin (ratio of highest IC50 lowest
IC50 is 2.4 for compound 1 and 1.8 for compound 4). Compound 6, the bromo analogue of
compound 4, shows both an enhanced cytotoxicity and differential activity (ratio of highest IC50
lowest IC5o is 7.3) compared with compound 1. The dimethylamino methyliodide salt, compound
5, is less cytotoxic than compound I but with an enhanced differential cytotoxicity (ratio of highest
IC50 :lowest IC50 is 4.5). The reduction in cytotoxicity is probably due to this being a charged
compound, whereas the other complexes are neutral. This would reduce its ability to cross cell
membranes and reach a putative intracellular target.
Complex 3, the diazaphospholanyl fermcene, is not cytotoxic, unlike the diphenylphosphino
ferrocene, compound 1. Interestingly, when coordinated to give the chlorogold complex,
compound 8, there is a dramatic increase in cytotoxicity. This is associated with an increase in
differential activity with an IC50 of 1.3 pg ml"1 for HT1376 and 19.6 pg ml"1 for SW620 giving a ratio
of highest IC50 :lowest IC50 of 19.1. This compound is also more toxic towards the HT1376 cell
line than compound 4, the chlorogold diphenylphosphine. Compound 7, the chlorogold
dimethylaminoethoxyphosphine, is similarly cytotoxic towards the HT1376 cell line with a ratio of
highest IC50 :lowest IC50 of 4.9.
These data indicate that the potency and differential cytotoxicity of phosphinogold(I)
ferrocenes can be changed by chemical modification.
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